Skip to content
PICO Portalanswers from OpenAlex

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL

PaperCitations, authors & open-access status

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL is a paper indexed in PICO Portal from OpenAlex.

How many citations does An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL have?

PICO Portalcitation count

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL has 27 citations in the OpenAlex counts PICO Portal stores.

When was An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL published?

PICO Portalyear

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL has 2019 year in the PICO Portal index.

What is the open-access status of An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL?

PICO Portaloa status

An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL has closed oa status in the PICO Portal index.

What is the DOI of An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL?

PICO Portaldoi

The DOI for An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL is on the source record.

What is the PMID of An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL?

PICO Portalpmid

The PMID for An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL is on the source record.

What is the OpenAlex record for An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL?

PICO Portalopenalex

The OpenAlex for An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial